Best Liver cancer stage 4 Doctors Worldwide — TOP 101

Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.

• Authored over 40 research publications focusing on tumor biology and immunology.
• Former Head of Internal Diseases at Istanbul Okan University Faculty of Medicine.
• Held leadership roles in medical oncology at GATA Haydarpasa Training Hospital.
• Member of the Turkish Medical Oncology Association and European Head and Neck Society.

Dr. Eda Tanrikulu specializes in medical oncology and chemotherapy at Anadolu Medical Center, affiliated with Johns Hopkins Medicine.

• Completed medical oncology training at Marmara University
• Ranked 3rd in Turkey for minor specialty exam
• Led medical oncology unit at Haydarpaşa Numune Training and Research Hospital
• Involved in international clinical studies in medical oncology

Dr. Abdulcabbar Kartal is a colorectal and general surgeon at Anadolu Medical Center. He specializes in HIPEC and bariatric surgery. He has performed over 500 bariatric procedures. Dr. Kartal holds certification from the European Society of Coloproctology (FEBS-C). He works at a clinic affiliated with Johns Hopkins Medicine.

• Completed over 650 surgical operations across major hospitals in Turkey.
• Certified by the Turkish Surgical Association for his surgical qualifications.
• Uses laser techniques for hemorrhoidal diseases and interventional endoscopic procedures.
• Member of the Turkish Association of Endoscopic Laparoscopic Surgery.

Dr. Banu Atalar is a professor and radiation oncologist at Anadolu Medical Center. She is an Honorary Fellow of the American College of Radiology (H.FACR). She completed a clinical research fellowship in stereotactic radiosurgery at Stanford University. Stereotactic radiosurgery and MR-guided adaptive SRS make up 75% of her clinical practice.

• President of the Turkish Society for Radiation Oncology.
• Chair of the ESTRO National Societies Committee.
• Recipient of the ASCO International Development and Education Award.
• Author of over 70 international peer-reviewed publications.

A leading global figure in cancer immunotherapy for over 44 years, Prof. Zielinski is one of Austria's most prominent oncologists. He currently chairs the Vienna Cancer Center and directs the International Oncology Center at Wiener Privatklinik.

• Founded and directed the Comprehensive Cancer Center Vienna (CCC)
• Former President of the Central European Cooperative Oncology Group (CECOG)
• Specialized in individualized cancer therapies and immuno-oncology
• Authored numerous papers in leading oncology journals
• His focus is on tailoring advanced treatments to a patient's specific tumor biology

Dr. Murat Dokdok is a specialized interventional radiologist at Anadolu Medical Center. He completed an interventional neuroradiology fellowship at the University Hospital of Zurich. Dr. Dokdok also held a fellowship at Harvard Medical School. He focuses on neurological therapy and imaging for conditions like cerebral aneurysms and liver cancer. Dr. Dokdok works at Anadolu, a facility affiliated with Johns Hopkins Medicine.

• Holds over 100 national and international scientific publications and presentations.
• Certified by the European Society of Neuroradiology.
• Member of the Cardiovascular and Interventional Radiology Society of Europe.
• Performs radiofrequency ablation and chemoembolization for oncology patients.

Dr. Huseyin Baloglu is a pathologist at Anadolu Medical Center in Turkey. He leads liquid biopsy and precision oncology services. Dr. Baloglu holds a patent for molecular diagnostics in thyroid cancer treatment. He completed training at Albert Einstein College of Medicine and Heidelberg University.

• Authored over 600 peer-reviewed publications in molecular and surgical pathology.
• Specializes in tumor biopsy, immunohistochemistry, and genetic mutation testing.
• Treats complex oncological cases, including glioblastoma and rare sarcomas.
• Works at Anadolu Medical Center, a facility affiliated with Johns Hopkins Medicine.

Dr. Pelles Sharon specializes in advanced liver cancer treatments at Sourasky Medical Center, including innovative therapies like SIRT and HIPEC.

• Offers comprehensive liver cancer treatments including chemotherapy and immunotherapy
• Performs liver resections and radiofrequency ablations
• Participates in clinical research on cancer treatments
• Provides targeted therapy and chemoembolization for liver cancer

Professor Ofer Merimsky leads the oncology department at Tel Aviv Medical Center, with over 41 years of experience in treating advanced cancers.

• Specializes in metastatic liver cancer and soft tissue tumors
• Fellowship-trained in Paris for bone and soft tissue oncology
• Active member of ESMO Sarcoma group and ASCO
• Published extensive research on cancer treatment outcomes

44 years specializing in liver and GI cancers – he leads the Cancer Prevention Center at Tel Aviv's Sourasky Medical Center.

• Publishes groundbreaking research on gene therapy for liver and GI tumors
• Author of over 300 scientific papers on cancer detection and treatment
• Trained in the US at the prestigious NewYork-Presbyterian Center
• Active member of the European Society of Digestive Oncology
• Head of the Cancer Prevention Center since 2002

Professor Pfaffenbach leads the Department of Gastroenterology, Oncology and Internal Medicine at the Academic Hospital Solingen, specializing in liver tumors and complex gastrointestinal conditions.

• Head of department since 2008 with over 34 years in gastroenterology and oncology
• Author of 130+ publications on digestive diseases and liver treatments
• Board-certified in gastroenterology and internal medicine with additional dietary therapy expertise
• Member of leading European and German gastroenterology societies

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. Ayshe Okumush is a radiation oncologist at Private NeoLife Medical Center. She earned her MD from Karadeniz Technical University in 2003. She completed a residency in radiation oncology at Sisli Etfal Training and Research Hospital from 2006 to 2011.

She served as a specialist at Diyarbakir Uckuyular Training and Research Hospital from 2011 to 2013 and at Sisli Etfal from 2013 to 2016. She then worked at Yeni Yuzyil University Private Gaziosmanpasa Hospital from 2016 to 2026. She joined NeoLife in 2026.

Memberships: Turkish Society for Radiation Oncology (TROD) and the European Society for Radiotherapy and Oncology (ESTRO). Clinical focus: SRS, SRT, SBRT; VMAT, IMRT; radiotherapy for head and neck, lung, and brain tumors; SGRT, TBI, and 3D brachytherapy.

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Prof. Sezer Sağlam leads the Medical Oncology Department at Gayrettepe Florence Nightingale Hospital, specializing in liver cancer care.

• Professor in Medical Oncology with extensive training in gastrointestinal oncology
• Member of prestigious societies including ESMO and ASCO
• Over 27 years of experience in medical oncology
• Special focus on liver and gastrointestinal cancers

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. Osama Abdel Mohimen Mohamed leads the Hematology Unit at Shefaa Al Orman Oncology Hospital. He treats complex blood cancers, including leukemia, lymphoma, and myeloma. Dr. Mohamed is a member of the European Society for Medical Oncology. He also holds memberships in the American Society of Hematology and ASBMT.

• Specializes in chemotherapy, immunotherapy, and bone marrow transplantation.
• Manages aggressive acute leukemia and chronic blood disorders.
• Treats complications arising from various solid tumors.
• Works at an ESMO-accredited center that handles 6,000 patients annually.

Dr. Einat Shacham Shmueli is a senior medical oncologist at Sheba Medical Center. She specializes in gastrointestinal cancers, treating the colon, stomach, and pancreas. Dr. Shacham Shmueli holds dual board certifications in oncology and gastroenterology. She trained at UCSF in the United States. Her clinic at Sheba Medical Center is ranked among the top 10 hospitals worldwide.

• Authored over 25 peer-reviewed publications on tumor biology and new treatments.
• Serves as an investigator for the National Cancer Institute (NCI) programs.
• Manages metastatic disease using precision diagnostics and specialized biomarkers.
• Member of the Israel Society of Oncology and Radiotherapy.

Professor Doctor Sefik Igdem specializes in radiation oncology, with advanced training in Truebeam Stx and Halcyon technologies at Gayrettepe Florence Nightingale Hospital.

• Expert in head and neck cancers and prostate cancer
• Uses conformal treatments for precise radiation therapy
• Associate Professor and later Professor at Demiroğlu Bilim University
• Trained at Istanbul University's Cerrahpaşa Faculty of Medicine

Dr. Mehmet Salih Iyikesici is a medical oncologist. His work focuses on metabolically supported chemotherapy (MSCT), ketogenic diet–supported cancer care, hyperthermia, hyperbaric oxygen therapy, and insulin potentiation therapy. He emphasizes care for breast, pancreatic, and gastric cancers.

He is a Medical Oncology Specialist at Neolife Medical Center (2026–present). He previously served at Private Bahçelievler Medical Park (2013–2026), Medicana Beylikdüzü (2010–2013), Silivri Anadolu (2009–2010), Diyarbakır Training and Research (2008–2009), and Bursa Çekirge State (2006–2008). Earlier, he worked as an Internal Medicine Specialist (1997–2003). He was an Assistant Professor at Altınbaş University (2014–2026).

Training: Medical Oncology subspecialty, Marmara University (2003–2006). Internal Medicine, Istanbul Haydarpaşa Numune (1992–1996). Medicine, Uludağ University (1985–1990). Member, Medical Oncology Association (since 2004). His recent research (2019–2020) covers gastric, breast, pancreatic, and lung cancers. Topics include long‑term survival in metastatic pancreatic cancer and feasibility in metastatic non‑small cell lung cancer (NSCLC).